Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Banner-University Medical Center Tuscon in Arizona is being penalized by Medicare for the third year in a row for a high rate of patients with injuries and infections, according to a report from the Arizona Daily Star.
For patients suffering from neuromuscular diseases, an eye-traacking technology may improve communication abilities. ClinicAll has developed a system that tracks eye movement to allow for communication in real-time.
As the number of minimally invasive surgical procedures grows, the value of the surgical equipment market is expected to escalate as well, to more than $20 billion by 2025.
Chicago’s Lurie Children’s Hospital has announced plans to increase its critical care services by almost 50 percent as part of a $51 million expansion.
The new year has brought the final approvals to legally integrate Pennsylvania’s Commonwealth Medical College into Geisinger Health System, creating the new Geisinger Commonwealth School of Medicine.
With photosynthesis, plants use sunlight to produce their own food. Dutch scientists have harnessed this type of approach to create an artificial leaf that uses a type of photosynthesis to create drugs wherever the sun shines.
The remote patient monitoring device market is expected to reach $1.9 billion in 2025 on a global basis, according to a new report from Research and Markets.
CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?
Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
